Log In
BCIQ
Print this Print this
 

ABX-1431

  Manage Alerts
Collapse Summary General Information
Company Abide Therapeutics Inc.
DescriptionSmall molecule inhibitor of monoacylglycerol lipase (MAGL), which regulates 2-arachidonoylglycerol (2-AG)
Molecular Target Monoacylglycerol lipase (MAGL)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Neurology (unspecified)
Indication DetailsTreat neurology indications
Regulatory Designation
PartnerCelgene Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/03/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today